Literature DB >> 1738465

Auditory attention in early Parkinson's disease: an impairment in focused attention.

M H Sharpe1.   

Abstract

Focused attention in the auditory modality was studied in a group of Parkinson patients and compared to matched controls using a Dichotic monitoring task. Parkinson patients detected more phonemic distractors on the unattended input than the normal controls, despite a high level of ipsilateral responses for target detection and target discrimination. This impairment in focused attention may be attributed to degenerative changes in the ascending monoamine pathways which have been implicated in the role of auditory attention.

Entities:  

Mesh:

Year:  1992        PMID: 1738465     DOI: 10.1016/0028-3932(92)90019-i

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  11 in total

1.  Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease.

Authors:  K Bronnick; U Ehrt; M Emre; P P De Deyn; K Wesnes; S Tekin; D Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

2.  Behavioral toxicology of cognition: extrapolation from experimental animal models to humans: behavioral toxicology symposium overview.

Authors:  Merle G Paule; Leonard Green; Joel Myerson; Maria Alvarado; Jocelyne Bachevalier; Jay S Schneider; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2012-01-28       Impact factor: 3.763

3.  Effects of stimulus-response compatibility in Parkinson's disease: a psychophysiological analysis.

Authors:  M Falkenstein; R Willemssen; J Hohnsbein; H Hielscher
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

4.  Cognitive improvement during Tolcapone treatment in Parkinson's disease.

Authors:  M Gasparini; E Fabrizio; V Bonifati; G Meco
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Evaluation of multi-feature auditory deviance detection in Parkinson's disease: a mismatch negativity study.

Authors:  Evelien De Groote; Annelies Bockstael; Dick Botteldooren; Patrick Santens; Miet De Letter
Journal:  J Neural Transm (Vienna)       Date:  2021-04-24       Impact factor: 3.575

6.  Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.

Authors:  Gunasingh Jeyaraj Masilamoni; Allison Weinkle; Stella M Papa; Yoland Smith
Journal:  Cereb Cortex       Date:  2022-04-20       Impact factor: 4.861

7.  Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Lacey Pflibsen; Katherine A Stang; Michelle D Sconce; Vanessa B Wilson; Rebecca L Hood; Charles K Meshul; Suzanne H Mitchell
Journal:  J Neurosci Res       Date:  2015-08-31       Impact factor: 4.164

8.  Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.

Authors:  E Decamp; J S Schneider
Journal:  Brain Res       Date:  2009-02-07       Impact factor: 3.252

9.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 10.  Parkinson's disease dementia: a neural networks perspective.

Authors:  James Gratwicke; Marjan Jahanshahi; Thomas Foltynie
Journal:  Brain       Date:  2015-04-16       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.